Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CSCO vs GSK✓SelectedUSD · GSKCSCO vs GSK performance historyLatest closeAs of+0.62%11/17
Stock and ETF performance explorer

CSCO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+92.2%
GSK return
+43.9%
Excess return
+48.2%
Maximum drawdown
-36.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.6%-2.3%+2.9%+0.9%
7D-3.1%-3.0%-0.1%-2.8%
30D-11.4%+0.4%-11.8%-11.5%
3M-15.4%-1.2%-14.2%-15.4%
6M-18.9%+0.9%-19.9%-19.2%
YTD+25.8%+4.0%+21.8%+24.2%
1Y+24.5%+7.3%+17.2%+22.4%
3Y+114.8%+57.1%+57.8%+94.0%
5Y+92.2%+43.0%+49.2%+59.8%
All+92.2%+43.9%+48.2%+59.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling